Research and innovation at the University of Utah continue to translate into real-world impact. The Orthopaedic Innovation Center has received FDA 510(k) clearance for the CoAptix™ S 7.5mm System—an advancement in orthopedic technology designed to improve healing and reduce complications for patients.
The CoAptix™ S system introduces a new approach to bone repair. In many orthopedic procedures, two sections of bone must heal together into a single, stable structure. A common complication, known as non-union, occurs when those bones fail to fuse—often leading to pain, instability, and additional surgery.
This system is designed to address that challenge directly. Unlike traditional implants that remain fixed after surgery, the CoAptix™ S functions as a dynamic, self-adjusting device. Once implanted, it continuously applies pressure to hold the bone segments together. If a small gap forms during the healing process, the implant automatically shortens—by up to 4mm—to maintain contact and stability where it matters most.
By preserving this constant compression, the technology supports the body’s natural healing process and helps reduce the risk of complications that can delay recovery or require further intervention.
The system includes a range of screw sizes and specialized surgical instruments, enabling surgeons to tailor treatment across a wide variety of procedures, including fracture repair, osteotomies, and joint fusions—areas that represent a significant portion of orthopedic care.
“This technology represents an important evolution in orthopedic fixation,” said Wade Fallin, Executive Director of the L. S. Peery, M.D. Orthopaedic Innovation Center. “Dynamic compression has demonstrated clear biomechanical and clinical advantages. With this platform, we are translating research into solutions that have the potential to improve outcomes for patients worldwide.”
The CoAptix™ S system is part of a broader platform of dynamic compression technologies under development, including additional implant sizes and intramedullary devices. The innovation is supported by a strong intellectual property portfolio, with six issued U.S. patents and additional applications pending.
For patients, the impact is clear: a higher likelihood of successful healing, fewer complications, and a reduced need for revision surgeries.
This milestone reflects the University of Utah’s commitment to advancing research that improves lives and strengthens society through meaningful innovation.
